How the Program Works FuturHealth combines GLP-1 prescription access with ongoing medical oversight and practical lifestyle guidance
It's shaping people's perceptions about weight loss, transforming attitudes towards obesity treatments, and most importantly, it's driving demand
Avoid injecting into bruised, scarred, red, or tender spots
Pharmacologic Treatment of Overweight and Obesity in Adults
Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials
In clinical trials, tirzepatide demonstrated significant reductions in hemoglobin A1c levels (up to 2.5% reduction in SURPASS diabetes trials) and body weight (up to 20% reduction in SURMOUNT obesity trials) compared to placebo and other medications